Bill Dudley, Bloomberg Opinion Columnist, Bloomberg Economics Senior Advisor and Former New York Fed President, says the Federal Reserve needs to get a lot more hawkish. Lori Calvasina, RBC Capital Markets Head of U.S. Equity Strategy, says the painful repricing we're seeing in markets still has a ways to go. Albert Bourla, Pfizer CEO, says investment in MRNA technology is a top priority. Francisco Blanch, Bank of America Commodities Research Head, expects to see triple digit oil in the second quarter. Dan Kurtz-Phelan, Foreign Affairs Editor, discusses the challenges China's President Xi is facing.